Literature DB >> 26642367

Loss of CD73-mediated actin polymerization promotes endometrial tumor progression.

Jessica L Bowser, Michael R Blackburn, Gregory L Shipley, Jose G Molina, Kenneth Dunner, Russell R Broaddus.   

Abstract

Ecto-5'-nucleotidase (CD73) is central to the generation of extracellular adenosine. Previous studies have highlighted a detrimental role for extracellular adenosine in cancer, as it dampens T cell-mediated immune responses. Here, we determined that, in contrast to other cancers, CD73 is markedly downregulated in poorly differentiated and advanced-stage endometrial carcinoma compared with levels in normal endometrium and low-grade tumors. In murine models, CD73 deficiency led to a loss of endometrial epithelial barrier function, and pharmacological CD73 inhibition increased in vitro migration and invasion of endometrial carcinoma cells. Given that CD73-generated adenosine is central to regulating tissue protection and physiology in normal tissues, we hypothesized that CD73-generated adenosine in endometrial carcinoma induces an innate reflex to protect epithelial integrity. CD73 associated with cell-cell contacts, filopodia, and membrane zippers, indicative of involvement in cell-cell adhesion and actin polymerization-dependent processes. We determined that CD73-generated adenosine induces cortical actin polymerization via adenosine A1 receptor (A1R) induction of a Rho GTPase CDC42-dependent conformational change of the actin-related proteins 2 and 3 (ARP2/3) actin polymerization complex member N-WASP. Cortical F-actin elevation increased membrane E-cadherin, β-catenin, and Na(+)K(+) ATPase. Together, these findings reveal that CD73-generated adenosine promotes epithelial integrity and suggest why loss of CD73 in endometrial cancer allows for tumor progression. Moreover, our data indicate that the role of CD73 in cancer is more complex than previously described.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26642367      PMCID: PMC4701552          DOI: 10.1172/JCI79380

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  110 in total

Review 1.  CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease.

Authors:  Federica Borghese; Felix I L Clanchy
Journal:  Expert Opin Ther Targets       Date:  2011-01-06       Impact factor: 6.902

2.  Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.

Authors:  Li Wang; Xuerui Zhou; Tingting Zhou; Dong Ma; Sifeng Chen; Xiuling Zhi; Lianhua Yin; Zhimin Shao; Zhouluo Ou; Ping Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

3.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

4.  HIF-dependent induction of adenosine A2B receptor in hypoxia.

Authors:  Tianqing Kong; Karen A Westerman; Marion Faigle; Holger K Eltzschig; Sean P Colgan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

5.  G-actin pool and actin messenger RNA during development of the apical processes of the retinal pigment epithelial cells of the chick.

Authors:  V T Nachmias; N Philp; Y Momoyama; J K Choi
Journal:  Dev Biol       Date:  1992-02       Impact factor: 3.582

6.  RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion.

Authors:  Xiuling Zhi; Sifeng Chen; Ping Zhou; Zhimin Shao; Li Wang; Zhouluo Ou; Lianhua Yin
Journal:  Clin Exp Metastasis       Date:  2007-06-21       Impact factor: 5.150

7.  Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.

Authors:  Xiuling Zhi; Yingjian Wang; Jerry Yu; Jiangang Yu; Liying Zhang; Lianhua Yin; Ping Zhou
Journal:  IUBMB Life       Date:  2012-11       Impact factor: 3.885

8.  HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.

Authors:  Holger K Eltzschig; Parween Abdulla; Edgar Hoffman; Kathryn E Hamilton; Dionne Daniels; Caroline Schönfeld; Michaela Löffler; German Reyes; Michael Duszenko; Jorn Karhausen; Andreas Robinson; Karen A Westerman; Imogen R Coe; Sean P Colgan
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

9.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

10.  Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.

Authors:  Edwin Bremer
Journal:  ISRN Oncol       Date:  2013-06-11
View more
  43 in total

Review 1.  Adenosinergic signaling as a target for natural killer cell immunotherapy.

Authors:  Jiao Wang; Sandro Matosevic
Journal:  J Mol Med (Berl)       Date:  2018-08-01       Impact factor: 4.599

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  The expression of the MSC-marker CD73 and of NF2/Merlin are correlated in meningiomas.

Authors:  Elmar Kirches; Tabea Steffen; Natalie Waldt; Eva Hebert; Doreen Pachow; Annette Wilisch-Neumann; Gerburg Keilhoff; Thomas Schneider; Werner E K Braunsdorf; Jan-Peter Warnke; Christian Mawrin
Journal:  J Neurooncol       Date:  2018-02-21       Impact factor: 4.130

Review 4.  The Hypoxia-Adenosine Link during Intestinal Inflammation.

Authors:  Jessica L Bowser; Luan H Phan; Holger K Eltzschig
Journal:  J Immunol       Date:  2018-02-01       Impact factor: 5.422

Review 5.  The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.

Authors:  Bertrand Allard; Maria Serena Longhi; Simon C Robson; John Stagg
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

6.  CD73s protection of epithelial integrity: Thinking beyond the barrier.

Authors:  Jessica L Bowser; Russell R Broaddus
Journal:  Tissue Barriers       Date:  2016-08-19

Review 7.  The hypoxia-adenosine link during inflammation.

Authors:  Jessica L Bowser; Jae W Lee; Xiaoyi Yuan; Holger K Eltzschig
Journal:  J Appl Physiol (1985)       Date:  2017-08-10

8.  Adenosine arrests breast cancer cell motility by A3 receptor stimulation.

Authors:  Carola Ledderose; Marco M Hefti; Yu Chen; Yi Bao; Thomas Seier; Linglin Li; Tobias Woehrle; Jingping Zhang; Wolfgang G Junger
Journal:  Purinergic Signal       Date:  2016-08-30       Impact factor: 3.765

Review 9.  Targeting immunosuppressive adenosine in cancer.

Authors:  Dipti Vijayan; Arabella Young; Michele W L Teng; Mark J Smyth
Journal:  Nat Rev Cancer       Date:  2017-10-23       Impact factor: 60.716

Review 10.  The adenosine pathway in immuno-oncology.

Authors:  Bertrand Allard; David Allard; Laurence Buisseret; John Stagg
Journal:  Nat Rev Clin Oncol       Date:  2020-06-08       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.